|4Jul 30, 4:30 PM ET

Townsend John 4

4 · Unicycive Therapeutics, Inc. · Filed Jul 30, 2025

Insider Transaction Report

Form 4
Period: 2025-07-28
Townsend John
Chief Financial Officer
Transactions
  • Award

    Stock Options

    2025-07-28+10,000101,557 total
    Exercise: $4.71Exp: 2035-07-28Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]2,500 of the stock options vest on July 28, 2026 and 1/36th of the remaining options vest at the end of each successive month thereafter.

Documents

1 file
  • 4
    ownership.xmlPrimary